Free Trial

Bio-Techne (TECH) News Today

→ Elon Musk’s Final Masterpiece: “X-9840” (From Paradigm Press) (Ad)
Free TECH Stock Alerts
$77.63
-1.20 (-1.52%)
(As of 06/7/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends
June 9 at 5:53 AM | marketbeat.com
Tower Research Capital LLC TRC Acquires 19,530 Shares of Bio-Techne Co. (NASDAQ:TECH)
Tower Research Capital LLC TRC raised its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 152.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 32,378 shares of the biotechnology company
June 8 at 6:12 AM | marketbeat.com
First Trust Advisors LP Boosts Position in Bio-Techne Co. (NASDAQ:TECH)
First Trust Advisors LP raised its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 27.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 739,694 shares of the biotechnology company's stock a
June 8 at 3:36 AM | americanbankingnews.com
Bio-Techne Co. (NASDAQ:TECH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
June 8 at 3:34 AM | marketbeat.com
Bio-Techne Co. (NASDAQ:TECH) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Bio-Techne Co. (NASDAQ:TECH - Get Free Report) have been given an average recommendation of "Moderate Buy" by the eleven brokerages that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy ra
June 6 at 7:45 PM | marketbeat.com
Public Employees Retirement Association of Colorado Buys 215,338 Shares of Bio-Techne Co. (NASDAQ:TECH)
Public Employees Retirement Association of Colorado boosted its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 7,628.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 21
June 4, 2024 | marketbeat.com
Rhenman & Partners Asset Management AB Has $1.24 Million Stake in Bio-Techne Co. (NASDAQ:TECH)
Rhenman & Partners Asset Management AB decreased its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 62.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,000 shares of the biotechnology company's stock af
June 3, 2024 | marketbeat.com
Stephens Investment Management Group LLC Has $53.12 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH)
Stephens Investment Management Group LLC lessened its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 1.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 688,417 shares of the biotechnology company's stock
June 2, 2024 | marketbeat.com
Bio-Techne Co. (NASDAQ:TECH) Shares Purchased by UBS Group AG
UBS Group AG lifted its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 405.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 142,949 shares of the biotechnology company's stock after acquiring an additional 114,648 shares during the q
June 2, 2024 | marketbeat.com
Polen Capital Management LLC Invests $1.73 Million in Bio-Techne Co. (NASDAQ:TECH)
Polen Capital Management LLC acquired a new position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 22,383 shares of the biotechnology company's stock, valued at a
June 1, 2024 | americanbankingnews.com
Bio-Techne (NASDAQ:TECH) Shares Down 4%
May 31, 2024 | prnewswire.com
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
May 30, 2024 | marketbeat.com
Bio-Techne (NASDAQ:TECH) Stock Price Down 4%
Bio-Techne (NASDAQ:TECH) Stock Price Down 4%
May 30, 2024 | marketbeat.com
Artisan Partners Limited Partnership Acquires Shares of 285,995 Bio-Techne Co. (NASDAQ:TECH)
Artisan Partners Limited Partnership acquired a new stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 285,995 shares of the biotechnology company's stock, valu
May 30, 2024 | prnewswire.com
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE
May 29, 2024 | prnewswire.com
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing
May 28, 2024 | marketbeat.com
Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by Jensen Investment Management Inc.
Jensen Investment Management Inc. lifted its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 24.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,060 shares of the biotec
May 27, 2024 | marketbeat.com
S&CO Inc. Boosts Stake in Bio-Techne Co. (NASDAQ:TECH)
S&CO Inc. lifted its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 126.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 59,710 shares of the biotechnology compan
May 24, 2024 | marketbeat.com
Norges Bank Acquires New Holdings in Bio-Techne Co. (NASDAQ:TECH)
Norges Bank acquired a new stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 1,552,240 shares of the biotechnology company's stock, valu
May 23, 2024 | marketbeat.com
Leavell Investment Management Inc. Lowers Holdings in Bio-Techne Co. (NASDAQ:TECH)
Leavell Investment Management Inc. cut its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 19.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 52,057 shares of the biotechnology company's stock after selling 12,
May 23, 2024 | finance.yahoo.com
Multiple Headwinds Dragged Bio-Techne Corp. (TECH) in Q1
May 23, 2024 | prnewswire.com
BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
May 22, 2024 | msn.com
Citigroup Downgrades Bio-Techne (TECH)
May 22, 2024 | msn.com
Citi downgrades Bio-Techne to neutral, cites valuation
May 22, 2024 | markets.businessinsider.com
Demystifying Bio-Techne: Insights From 4 Analyst Reviews
May 22, 2024 | marketbeat.com
Corient Private Wealth LLC Raises Stock Position in Bio-Techne Co. (NASDAQ:TECH)
Corient Private Wealth LLC increased its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 4,482.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 633,790 shares of the biotechnology company's stock after acqu
May 22, 2024 | marketbeat.com
Bio-Techne (NASDAQ:TECH) Downgraded to "Neutral" at Citigroup
Citigroup downgraded shares of Bio-Techne from a "buy" rating to a "neutral" rating and set a $85.00 price objective on the stock. in a research report on Wednesday.
May 22, 2024 | prnewswire.com
BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY
May 21, 2024 | marketbeat.com
Assenagon Asset Management S.A. Sells 102,916 Shares of Bio-Techne Co. (NASDAQ:TECH)
Assenagon Asset Management S.A. reduced its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 76.3% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 31,899 shares of the biotechnology company's stock
May 21, 2024 | businesswire.com
Court Revokes Two Advanced Cell Diagnostics Patents, Dismisses Infringement Claims Against Molecular Instruments and Orders Advanced Cell Diagnostics to Make Payment of £1.35 Million to Molecular Instruments
May 20, 2024 | investorplace.com
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
May 19, 2024 | marketbeat.com
Brown Advisory Inc. Purchases 741,860 Shares of Bio-Techne Co. (NASDAQ:TECH)
Brown Advisory Inc. raised its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 1,094.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 809,635 shares of the biotechnology company's stock after
May 18, 2024 | nz.finance.yahoo.com
Bio-Techne Corp (TE1.SG)
May 18, 2024 | marketbeat.com
Jackson Square Partners LLC Has $115.52 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH)
Jackson Square Partners LLC boosted its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 18.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,497,086 shares of the biotechnology company's stock
May 17, 2024 | marketbeat.com
Massachusetts Financial Services Co. MA Boosts Stock Position in Bio-Techne Co. (NASDAQ:TECH)
Massachusetts Financial Services Co. MA grew its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 1,389.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 784,543 shares of the biotechnology
May 16, 2024 | marketbeat.com
Bio-Techne Co. (NASDAQ:TECH) Shares Purchased by Victory Capital Management Inc.
Victory Capital Management Inc. grew its stake in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 56.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,936 shares of the b
May 14, 2024 | finance.yahoo.com
Bio-Techne Corporation (TECH) Declined on Weak Q4 Results
May 13, 2024 | marketbeat.com
Bio-Techne Co. (NASDAQ:TECH) Stock Holdings Decreased by Summit Creek Advisors LLC
Summit Creek Advisors LLC reduced its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 7.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 263,902 shares of the biotechnology company's stock after selling 20,779 shares during the period. B
May 12, 2024 | marketbeat.com
Charles Schwab Investment Management Inc. Grows Position in Bio-Techne Co. (NASDAQ:TECH)
Charles Schwab Investment Management Inc. lifted its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 2.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,439,919 shares of
May 9, 2024 | finance.yahoo.com
Bio-Techne Third Quarter 2024 Earnings: Beats Expectations
May 8, 2024 | prnewswire.com
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
May 8, 2024 | marketbeat.com
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Swiss National Bank
Swiss National Bank cut its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 2.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 494,900 shares of the biotechnology company's stock after sellin
May 7, 2024 | marketbeat.com
Bio-Techne Co. (NASDAQ:TECH) Shares Purchased by Spire Wealth Management
Spire Wealth Management raised its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 38,075.5% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 59,172 shares of the biotechnology company's stock after purchasing an additional 59,
May 7, 2024 | prnewswire.com
BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
May 6, 2024 | marketbeat.com
Natixis Advisors L.P. Has $21.93 Million Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)
Natixis Advisors L.P. boosted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 28.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 284,192 shares of the biotechnology compan
May 4, 2024 | finance.yahoo.com
Bio-Techne Corporation Just Recorded A 7.6% EPS Beat: Here's What Analysts Are Forecasting Next
May 4, 2024 | marketbeat.com
Russell Investments Group Ltd. Acquires 83,569 Shares of Bio-Techne Co. (NASDAQ:TECH)
Russell Investments Group Ltd. lifted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 65.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 212,227 shares of the b
May 3, 2024 | marketbeat.com
Van ECK Associates Corp Sells 22,664 Shares of Bio-Techne Co. (NASDAQ:TECH)
Van ECK Associates Corp lessened its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 13.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 142,901 shares of the biotechno
May 2, 2024 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Cross Country Healthcare (CCRN) and Bio-Techne (TECH)
May 2, 2024 | marketbeat.com
Bio-Techne's (TECH) "Buy" Rating Reiterated at Benchmark
Benchmark reiterated a "buy" rating and issued a $95.00 price objective on shares of Bio-Techne in a research report on Thursday.
May 2, 2024 | marketbeat.com
Bio-Techne (NASDAQ:TECH) Posts Earnings Results, Beats Estimates By $0.03 EPS
Bio-Techne (NASDAQ:TECH - Get Free Report) posted its quarterly earnings data on Wednesday. The biotechnology company reported $0.48 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.03. The business had revenue of $303.43 million for the quarter, compared to analyst estimates of $292.36 million. Bio-Techne had a return on equity of 14.21% and a net margin of 19.58%. The business's revenue for the quarter was up 3.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.47 earnings per share.
Get Bio-Techne News Delivered to You Automatically

Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter.

Elon Musk’s Final Masterpiece: “X-9840” (Ad)

The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.

Click here to see the details because there’s not much time to prepare.

TECH Media Mentions By Week

TECH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TECH
News Sentiment
▼
1.38

0.75
▲
Average
Medical
News Sentiment

TECH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TECH Articles
This Week
▼
7

6
▲
TECH Articles
Average Week

Get Bio-Techne News Delivered to You Automatically

Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:TECH) was last updated on 6/9/2024 by MarketBeat.com Staff

From Our Partners
Breaking - The US Gov. Seized CITGO
Do you want an investment that can double or triple your money in the next three months? The US Court is cu...
Augury Research | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
Urgent alert: open this for a huge profit potential
This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...
Timothy Sykes | Sponsored
Who are Nvidia’s Silent Partners?
Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.
Weiss Ratings | Sponsored
Are You Positioned For The New Energy Goldrush?
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored
RSVP: Charles Payne’s Cash Flow Workshop
Did you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...
Unstoppable Prosperity | Sponsored